Journal:
:iranian journal of allergy, asthma and immunology
0
negin hosseini rouzbahani department of immunology, faculty of medicine, tarbiat modares university of medical sciences, tehran, iran
saeed bayanolhagh iranian research center for hiv/aids, iranian institute for reduction of high risk behaviors, tehran university of medical sciences, tehran, iran
mohammad gholami iranian research center for hiv/aids, iranian institute for reduction of high risk behaviors, tehran university of medical sciences, tehran, iran
ali esmaeilzadeh iranian research center for hiv/aids, iranian institute for reduction of high risk behaviors, tehran university of medical sciences, tehran, iran
zahra bayat jozani iranian research center for hiv/aids, iranian institute for reduction of high risk behaviors, tehran university of medical sciences, tehran, iran
minoo mohraz iranian research center for hiv/aids, iranian institute for reduction of high risk behaviors, tehran university of medical sciences, tehran, iran
vaccines against the hiv-1 virus offers the best hope for eliminating hiv-associated mortality. recombinant adenovector type 5 (rad5) vaccine is a potential candidate for preventive vaccine strategies. in this study, we evaluated the rad5 prime/protein boost strategy in a murine model. we used rad5 harboring single hiv-1 genes. these genes, including gag (p24) and exon1 of tat, were amplified f...